Get the Stockscreener App
5.81
3.17%
-0.19
After Hours:
5.77
-0.04
-0.69%
Teladoc Health Inc stock is traded at $5.81, with a volume of 3.51M.
It is down -3.17% in the last 24 hours and down -10.62% over the past month.
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.
See More
Previous Close:
$6.00
Open:
$5.81
24h Volume:
3.51M
Relative Volume:
0.88
Market Cap:
$1.06B
Revenue:
$2.51B
Net Income/Loss:
$-171.15M
P/E Ratio:
-6.0314
EPS:
-0.9633
Net Cash Flow:
$122.59M
1W Performance:
+4.50%
1M Performance:
-10.62%
6M Performance:
+10.88%
1Y Performance:
-34.94%
1-Day Range:
$5.71
$5.96
1-Week Range:
$5.42
$6.175
52-Week Range:
$4.40
$9.8868
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, BTSG, TEM, HNGE, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
5.81 | 1.06B | 2.51B | -171.15M | 122.59M | -0.9633 |
VEEV
Veeva Systems Inc
|
297.35 | 48.14B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
63.35 | 12.53B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
68.32 | 12.40B | 1.36B | -302.91M | -219.93M | -1.7182 |
HNGE
Hinge Health Inc
|
105.00 | 8.47B | 646.34M | -512.40M | 202.76M | -6.6871 |
HQY
Healthequity Inc
|
89.87 | 7.43B | 1.34B | 230.70M | 440.96M | 2.6695 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-26-26 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Jul-25-25 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Reiterated | Jefferies | Hold |
| Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
Holafly lance Ultra, un forfait eSIM international intégrant des services dédiés à la santé et au bien-être - GlobeNewswire Inc.
Should Teladoc’s New AI Tools for Solo Platform Require Action From Teladoc Health (TDOC) Investors? - Yahoo Finance
A fund adviser reports 9.1 million Teladoc Health (TDOC) shares held by its funds. - Stock Titan
Teladoc Strengthens Solo Platform With New AI-Powered Care Tools - Zacks Investment Research
Teladoc Strengthens Solo Platform With New AI-Powered Care Tools - TradingView
Teladoc Health (TDOC) Could Be 63% Undervalued Following Its New AI Tools - Yahoo Finance
Teladoc Health Adds Contactless Vitals and Ambient AI Scribe to Virtual Visit Platform - MedCity News
Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Zacks Investment Research
AI Tracker: Teladoc launches new AI features - Modern Healthcare
Teladoc unveils remote monitoring, ambient AI features - Healthcare Dive
What's Going On With Teladoc Health Stock Wednesday?Teladoc Health (NYSE:TDOC) - Benzinga
Teladoc Turns Smartphone Cameras Into AI-Powered Vital Sign Monitors - Yahoo Finance
A phone camera can measure a patient's pulse and breathing without touch. Teladoc adds AI visit notes. - Stock Titan
Teladoc Health Expands Solo Connected Care Platform with - GlobeNewswire
3 Undervalued Healthcare Stocks Invstors Can Buy Right Now - The Motley Fool
Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Zacks Investment Research
Teladoc Health Announces Chief Legal Officer Transition - GlobeNewswire
After 11 years, Teladoc Health's legal chief will leave Nov. 1; Dorfman succeeds him Nov. 2. - Stock Titan
Teladoc Health stock falls 3.46 percent after weak Q2 revenue - ad-hoc-news.de
Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note - Zacks Investment Research
Teladoc Health stock holds near USD 6.26 as revenue pressure persists - AD HOC NEWS
Teladoc Health CEO Charles Divita sells $108,681 in shares By Investing.com - Investing.com South Africa
Teladoc Health CEO Charles Divita sells $108,681 in shares - Investing.com
The Bull Case For Teladoc Health (TDOC) Could Change Following Weak Q2 Results And Lowered Guidance - finance.yahoo.com
Teladoc Health (TDOC) Slips 2.20% to $6.43, Drifting Toward Key SupportInstitutional Volume - careplusvn.com
Teladoc Share PriceTDOC, RNS News, Articles, Quotes, & Charts (NYSE:TDOC) - Proactive financial news
Teladoc: Integrated Care And Free Cash Flow Could Bring It Back To Life - Seeking Alpha
Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144 - moomoo.com
Why Teladoc (TDOC) Outpaced the Stock Market Today - Yahoo Finance
Teladoc Health (TDOC) executive plans 17.8K-share stock sale - Stock Titan
Avoiding Lag: Real-Time Signals in (TDOC) Movement - Stock Traders Daily
2 Beaten-Down Stocks to Avoid Right Now - The Globe and Mail
2 Beaten-Down Stocks to Avoid Right Now - finance.yahoo.com
2 Beaten-Down Stocks to Avoid Right Now - theglobeandmail.com
Here's Why Teladoc's Integrated Care Business Deserves More Attention - The Globe and Mail
Here's Why Teladoc's Integrated Care Business Deserves More Attention - TradingView
Here's Why Teladoc's Integrated Care Business Deserves More Attention - Yahoo Finance
Teladoc Health | 4: Statement of changes in beneficial ownership of securities-Officer Bliss Kelly - Moomoo
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - GlobeNewswire
Teladoc Health (TDOC) CEO sells 18,327 shares after stock awards vest - Stock Titan
Equity awards vest for Teladoc Health (NYSE: TDOC) accounting chief - Stock Titan
15,311 stock units vest for Teladoc (TDOC) exec as she sells shares for taxes - Stock Titan
Teladoc Health (TDOC) exec sells shares to cover taxes after 14,928 units vest - Stock Titan
RSU vesting prompts Teladoc (TDOC) executive to sell shares for taxes - Stock Titan
Teladoc Health (NYSE: TDOC) president sells 15,251 shares - Stock Titan
Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Teladoc Health (NYSE: TDOC) officer plans sale of 9,812 recently vested shares - Stock Titan
The Escalator: GSK, Teladoc, FINN Partners and more - Medical Marketing and Media
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - Yahoo Finance
Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Teladoc Health Inc Stock (TDOC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DIVITA CHARLES III | Officer |
Sep 11 '26 |
Proposed Sale |
6.10 |
17,805 |
108,684 |
0 |
| DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER |
Sep 11 '26 |
Sale |
6.10 |
17,805 |
108,682 |
465,535 |
| Rodrigues Fernando M. | Officer |
Sep 03 '26 |
Proposed Sale |
6.51 |
9,812 |
63,876 |
0 |
| DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER |
Sep 02 '26 |
Sale |
6.30 |
18,327 |
115,478 |
440,538 |
| Bliss Kelly | Officer |
Sep 02 '26 |
Proposed Sale |
6.30 |
7,357 |
46,359 |
0 |
| DIVITA CHARLES III | Officer |
Sep 02 '26 |
Proposed Sale |
6.30 |
18,327 |
115,484 |
0 |
| Nueno Carlos | Officer |
Sep 02 '26 |
Proposed Sale |
6.30 |
6,200 |
39,068 |
0 |
| Vandervoort Adam C | Officer |
Sep 02 '26 |
Proposed Sale |
6.30 |
7,573 |
47,720 |
0 |
| Rodrigues Fernando M. | Officer |
Sep 02 '26 |
Proposed Sale |
6.30 |
5,439 |
34,273 |
0 |
| Nueno Carlos | President, International |
Sep 02 '26 |
Sale |
6.30 |
6,200 |
39,066 |
64,744 |
0.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):